Originally funded by the Wellcome Trust, the Scottish National Blood Transfusion Service established a blood donor derived, anti-Epstein-Barr virus (EBV) Cytotoxic T-Cell bank. Donor cells are selected based on the best tissue match for the patient and administered in hospital under the close supervision of a medical team. The bank is now funded by cost-recovery charges from users.
The bank is licensed by the Medicine and Healthcare Products Regulatory Agency (MHRA) for the manufacture of unlicensed medicinal products under the terms of Manufacturer's ("Specials") Licence MS 3473. This means that SNBTS can manufacture and supply unlicensed medicines to meet the special needs of individual patients under the direct personal responsibility of the prescriber.
If you require more information about the bank, or would like to request Cytotoxic T-Cells contact the Cytotoxic T-Cell bank (email@example.com)Contact the Cytotoxic T-Cell bank by email (external link) Access resources about Cytotoxic T-Cell Therapy for clinicians